UMass Chan Licenses SiRNA Therapy to PLaN Therapeutics
January 23, 2026
January 23, 2026
WORCESTER, Massachusetts, Jan. 23 -- The University of Massachusetts Chan Medical School issued the following news:
* * *
UMass Chan licenses siRNA therapy to PLaN Therapeutics
Research collaboration will advance an allele-specific treatment for PLN-R14del cardiomyopathy, a rare, inherited heart disease
By Jim Fessenden
Technology developed by pioneering small interfering RNA (siRNA) chemists Anastasia Khvorova, PhD, the Remondi Fa . . .
* * *
UMass Chan licenses siRNA therapy to PLaN Therapeutics
Research collaboration will advance an allele-specific treatment for PLN-R14del cardiomyopathy, a rare, inherited heart disease
By Jim Fessenden
Technology developed by pioneering small interfering RNA (siRNA) chemists Anastasia Khvorova, PhD, the Remondi Fa . . .
